Sat.Jan 07, 2023 - Fri.Jan 13, 2023

article thumbnail

The importance of AI literacy in life sciences

pharmaphorum

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

Education 125
article thumbnail

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint

Fierce Pharma

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55

Sales 336
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

It is the time of year when everyone predicts what the next 12 months will hold. At Impetus Digital, we get a first-hand look into evolving industry trends daily from our clients and their advisors, putting us in a unique position to make these predictions.

Pharma 110
article thumbnail

Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff

PharmExec

As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.

110
110
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Bayer taps Google’s quantum power for drug discovery

pharmaphorum

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules at the atomic scale.

Pharma 122

More Trending

article thumbnail

Space — the next frontier in drug development

PharmaVoice

Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients

Leads 105
article thumbnail

Cybersecurity Threats & Pharma

PharmExec

The steps companies can take now to better protect themselves and their data.

Pharma 109
article thumbnail

AI and the Big Data paradigm – big ambitions in novel drug discovery

pharmaphorum

Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information.

Pharma 122
article thumbnail

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023

Fierce Pharma

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023. kdunleavy. Mon, 01/09/2023 - 10:34

Sales 307
article thumbnail

Why you should include your residents in your senior living marketing

Clear Pivot

Your website is one of the most important tools you have to communicate what your senior living community is all about. And what better way to showcase that than involving your residents?

Media 98
article thumbnail

Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study

Legacy MEDSearch

Hip Innovation Technology , LLC (HIT), a medical device company developing innovative orthopaedic device solutions to advance the quality of life and quality of care for patients, is pleased to announce the first U.S.

article thumbnail

JP Morgan 2023 – Pre event

pharmaphorum

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday.

Pharma 122
article thumbnail

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share

Fierce Pharma

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24

Marketing 298
article thumbnail

Woman of the Week: Form Bio’s Claire Aldridge

PharmaVoice

The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution

98
article thumbnail

Application of machine learning tools for predicting impact of punch cup depth on tablet capping

PharmaTech

We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.

article thumbnail

Astellas licenses companion drug for Pompe gene therapy

pharmaphorum

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease.

Pharma 119
article thumbnail

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals

Fierce Pharma

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals. kdunleavy. Tue, 01/10/2023 - 06:24

Pharma 285
article thumbnail

Biopharma Investment Implications: Looking Back and Forward

PharmExec

What a changing economy and related trends could mean for 2023.

article thumbnail

How biotechs can weather the market storm

PharmaVoice

Execs at JPM sound off on moves companies can make to survive the challenging market conditions

article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company.

article thumbnail

JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amyrt buyout

Fierce Pharma

JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amyrt buyout. esagonowsky. Mon, 01/09/2023 - 08:14

Pharma 276
article thumbnail

VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System

Legacy MEDSearch

VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, announced FDA approval of the newest generation of its tankless inhaled nitric oxide (iNO) delivery system. .

article thumbnail

The kindred nature of martial arts and drug development

PharmaVoice

How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments

98
article thumbnail

JP Morgan 2023 – Day 1

pharmaphorum

We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.

FDA 119
article thumbnail

AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use

Fierce Pharma

AstraZeneca's first-in-class rescue inhaler Airsupra wins FDA nod—but only for adult use. esagonowsky. Wed, 01/11/2023 - 09:03

FDA 268
article thumbnail

Upgrading Omnichannel Coordination to Improve Customer Centricity

PharmExec

"The customer is always right" — a commitment to omnichannel marketing is a commitment to serving the customer. David Laros of Beghou Consulting offers up this tersely written playbook on the topic.

article thumbnail

Sun Pharma- Walk-In Drive for QC/ Production On 8th Jan’ 2023 & Send Resumes for Engineering/ QA/ Warehouse

Pharma Pathway

Sun Pharma- Walk-In Drive for QC/ Production On 8th Jan’ 2023 & Send Resumes for Engineering/ QA/ Warehouse. Job Description. Walk-In Interview for Sun Pharma, Paonta Sahib On 8th Jan’ 2023. We are Hiring @ Sun Pharma, Paonta Sahib. Department: QC/ Production.

article thumbnail

BioNTech buys UK-based AI startup InstaDeep in £562m deal

pharmaphorum

mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 million ($683 million).

article thumbnail

Lilly, Biogen and more gear up for blockbuster launches in 2023: report

Fierce Pharma

Lilly, Biogen and more gear up for blockbuster launches in 2023: report. kdunleavy. Wed, 01/11/2023 - 10:19

Pharma 268
article thumbnail

Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries

Legacy MEDSearch

Lydus Medical is pleased to announce that the Vesseal has received FDA clearance 510(k). The Vesseal is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.

article thumbnail

Drug Solutions Podcast: Pharma Trends Dissected by 3 PR Agency Luminaries

PharmaTech

Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications.

article thumbnail

California sues insulin producers and PBMs over pricing

pharmaphorum

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products.

article thumbnail

JPM23: Regeneron reports disappointing sales of powerhouse Eylea, says it's a 'blip'

Fierce Pharma

JPM23: Regeneron reports disappointing sales of powerhouse Eylea, says it's a 'blip'. kdunleavy. Mon, 01/09/2023 - 14:21

Sales 265